Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 599 of 6351
-
New combo aims to beat bladder cancer without bladder removal
Disease control Recruiting nowThe goal of this clinical trial is to learn if gemcitabine/cisplatin plus cemiplimab with or without fianlimab works to treat bladder cancer in adults. The main question it aims to answer is: Can gemcitabine, cisplatin, and cemiplimab with or without fianlimab treat bladder cance…
Phase 2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 26, 2026 12:38 UTC
-
Experimental combo targets Hard-to-Treat blood cancer
Disease control Recruiting nowThis phase I trial tests the safety and side effects of zanubrutinib in combination with odronextamab and how well it works in treating patients with Richter's transformation. Zanubrutinib, a tyrosine kinase inhibitor, blocks a protein called Bruton tyrosine kinase (BTK), which m…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 26, 2026 17:45 UTC
-
New patch aims to speed healing of stubborn diabetic foot sores
Disease control Recruiting nowThis study will evaluate a cellular, acellular, matrix-like product (CAMP) and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs). The study will evaluate Amnio-Maxx® Dual Layer Amnion Patch.
Phase 4 • Sponsor: Royal Biologics • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for lymphoma patients: drug combo trial launches
Disease control Recruiting nowThis is an open-label, multicenter, phase 2, non-randomized study aiming to evaluate the efficacy and safety of orelabrutinib combined with zebetuzumab and lenalidomide or bendamustine combined with rituximab in the treatment of newly diagnosed marginal zone lymphoma (MZL).
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a Clot-Buster help stroke patients on blood thinners?
Disease control Recruiting nowAn investigator-initiated, multicenter, randomized, placebo-controlled, double-blind trial to determine the efficacy and safety of intravenous tenecteplase thrombolysis in acute ischemic stroke (AIS) patients with recent direct oral anticoagulants (DOACs) intake in improving the …
Phase 3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug duo aims to tackle Hard-to-Treat myeloma
Disease control Recruiting nowThis is an open-label phase 2 study of elranatamab in combination with isatuximab administered subcutaneously in patients with relapsed and refractory multiple myeloma (RRMM) who have received at least two prior lines of therapy and who have had previous treatment with both immun…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New program aims to keep At-Risk teens safe by building a 'Village of Care'
Disease control Recruiting nowThe goal of this pilot randomized control trial (RCT) is to test the feasibility of Caring Connections, a Culturally Adapted Linking Individuals Needing Care (CA-LINC) suicide prevention care coordination intervention for high-risk suicidal youth. This consumer-, community-, and …
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Video game for the brain: could neurofeedback supercharge Post-Surgery recovery?
Disease control Recruiting nowAfter orthopedic surgeries like knee or hip replacement, some patients struggle to fully activate their muscles due to a condition called Arthrogenic Muscle Inhibition (AMI). AMI can slow recovery and make physical therapy less effective. This clinical trial is testing whether a …
Phase 2 • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
AI chatbot coaches brain injury patients to walk their way to better health
Disease control Recruiting nowThis study aims to develop and evaluate an AI-driven Personalized Exercise Feedback Program (AI-PEF) to enhance health outcomes in mTBI patients. Methods: AI-PEF integrates the transtheoretical model and self-determination theory with machine learning algorithms to provide real-…
Sponsor: National Defense Medical Center, Taiwan • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can an Immune-Modulating drug clear Alzheimer's brain plaques?
Disease control Recruiting nowThe purpose of this study is to investigate the benefits of ozanimod in patients with moderate Alzheimer's disease.
Phase 2 • Sponsor: ChenXiaoChun • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New hope for tough head and neck cancers: experimental combo trial launches
Disease control Recruiting nowThis is a non-randomized, open-label, dose-escalation and dose-expansion phase I/II clinical study to evaluate the safety, tolerability, and efficacy of HCB101 in combination with pembrolizumab in patients with platinum-refractory recurrent/metastatic HNSCC. The trial consists of…
Phase 1/2 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New mRNA vaccine aims to shield seniors from RSV
Vaccine OngoingThe study will evaluate the safety, tolerability, and immunogenicity of 2 dose levels of IN006 in healthy participants who aged at 60 years or older; of a revaccination of IN006 given 12 months or 24 months after the initial vaccination.
Phase 2 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: Vaccine
Last updated Jun 26, 2026 14:29 UTC
-
Can a new tracer match the gold standard for heart scans?
Diagnosis By invitation onlyThis study seeks to evaluate if the diagnostic performance of 18F-flurpiridaz positron emission tomography (PET) myocardial perfusion imaging (MPI), given the radiotracer's properties, is non-inferior to the currently most widely utilized PET MPI radiopharmaceutical, 82Rb-chlorid…
Sponsor: University of California, Los Angeles • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC
-
New injection could ease sleep apnea in obese patients
Disease control Recruiting nowThis study is a phase 3 clinical trial, aiming to evaluate the efficacy and safety of HRS-9531 injection in obese subjects with obstructive sleep apnea (OSA) who are on positive airway pressure ventilation (PAP) therapy.
Phase 3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Double donor transplant trial aims to boost survival in blood cancer patients
Disease control Recruiting nowThe purpose of this study is to see if see if adding the specific combination of donors can result in acceptable levels of survival without evidence of disease.
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a simple blood test spare thousands from chemo?
Disease control Recruiting nowThe goal of this performance study is to learn if treatment with neoadjuvant endocrine therapy compared to chemotherapy has comparable efficacy, but better quality of life outcomes in endocrine responsive participants with early and locally advanced ER+/HER2-negative breast cance…
Sponsor: Austrian Breast & Colorectal Cancer Study Group • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could a common steroid help brain bleed survivors walk again?
Disease control Recruiting nowA multi-centre, prospective, blinded, randomised clinical trial of fludrocortisone compared with placebo in patients presenting with aneurysmal subarachnoid haemorrhage. The study aim is to determine if early administration of enteral fludrocortisone in aneurysmal subarachnoid h…
Phase 2 • Sponsor: The George Institute • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can tiny beads block pain signals from arthritic spine joints?
Disease control Recruiting nowThis single-site, single-arm study evaluates the feasibility, safety, tolerability, and efficacy of trans-arterial embolization (TAE) using Embozene microparticles for treating facetogenic pain due to facet arthropathy (osteoarthritis of the facet joints) in the lumbar spine.
Sponsor: Northwell Health • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New radioactive treatment shows promise before prostate surgery
Disease control Recruiting nowThis is a multi-disciplinary collaboration between urologists, oncologists and nuclear medicine physicians from Beilinson hospital at Rabin Medical Center to address the major therapeutic challenge of locally advanced prostate cancer. Our aim is to evaluate the use of a novel tre…
Phase 1/2 • Sponsor: Rabin Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New pill aims to cut sickle cell pain attacks in half
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, flexible-adaptive, group-sequential study (Part A), followed by an open-label LTE period (Part B) to investigate the efficacy, and safety of rilzabrutinib in participants with sickle-cell disease…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC